Mitsubishi Tanabe Pharma ordered to suspend some operations

Mitsubishi Tanabe Pharma ordered to suspend some operations

TOKYO, Japan - Mitsubishi Tanabe Pharma Corp. President Michihiro Tsuchiya (L) and Takehiko Fujii (C), president of subsidiary Bipha Corp., apologize in Tokyo on April 13, 2010, after the Health, Labor and Welfare Ministry ordered Mitsubishi Tanabe Pharma to suspend some of its pharmaceutical manufacturing and sales operations for 25 days over the alleged falsification of blood product test data. The subsidiary, which manufactured the product and falsified the data, was ordered to suspend its drug manufacturing business for 30 days. (Kyodo)

  • Product Code
  • ILEA000345918
  • Registered date
  • 2010/4/13 00:00:00
  • Credit
  • Kyodo / Kyodo News Images
  • Media source
  • Media size
  • 2711 × 1680 pixel
  • Resolution
  • 240 dpi
  • Deployment size
  • 1.10(MB)*
  • Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos
    Mitsubishi Chemical HD to make Mitsubishi Tanabe Pharma Corporation a wholly owned subsidiary

    Mitsubishi Chemical HD to make Mitsubishi Tanabe Pharma Corporation a wholly owned subsidiary

    Mitsubishi Chemical Holdings (HD) announced on the 18th that it will invest up to 491.8 billion yen to make its consolidated subsidiary Mitsubishi Tanabe Pharma Corporation a wholly owned subsidiary. Currently, MCHC holds 56.39% of Mitsubishi Tanabe Pharma's shares, and will conduct a tender offer from January 19 to January 7, 2020, aiming to make Mitsubishi Tanabe Pharma its wholly owned subsidiary. At a press conference in Tokyo on January 18, MCHC President Hitoshi Ochi said, "The world is evolving greatly and healthcare is developing at a very fast pace. Mitsubishi Tanabe Pharma will also accelerate the overseas development of promising new drug candidates by using MCHC's human resources. The company will utilize the diverse resources of a comprehensive chemical manufacturer to efficiently create new businesses and enhance the earnings structure of a core healthcare company. (November 18, 2019, Tokyo, Japan; Credit: Nikkan Kogyo Shimbun / Kyodo News Images)
      Novartis Pharma accused over drug ads

      Novartis Pharma accused over drug ads

      TOKYO, Japan - Health, Labor and Welfare Ministry officials hold a press conference at the ministry in Tokyo on Jan. 9, 2014, after filing a criminal complaint with prosecutors against Novartis Pharma K.K. over alleged exaggerated advertising for a blood pressure-lowering drug.
        Sapporo to make Pokka subsidiary

        Sapporo to make Pokka subsidiary

        TOKYO, Japan - Sapporo Holdings Ltd. Managing Director Tsutomu Kamijo (L), who is set to become the next president of the holding firm of beverage makers, Masatoshi Hori, president of another beverage producer Pokka Corp. (C) and Takao Murakami, current president of Sapporo Holdings (R), shake hands during a press conference in Tokyo on Feb. 10, 2011. The two companies said Sapporo will turn Pokka into a subsidiary in late March as a first step to integrate their management in April 2012, in an effort to better compete in drink and food markets amid an adverse business environment. (Kyodo)
          Toyota, Fuji Heavy, Daihatsu to enhance cooperation

          Toyota, Fuji Heavy, Daihatsu to enhance cooperation

          TOKYO, Japan - Fuji Heavy Industries Ltd. President Ikuo Mori (L), Toyota Motor Corp. President Katsuaki Watanabe (C) and Daihatsu Motor Co. President Teruyuki Minoura pose for photos after their joint news conference at a hotel in Tokyo on April 10. The presidents announced that the three companies have agreed to enhance business cooperation in the development and production of automobiles to improve their competitiveness. (Kyodo)
            Fujifilm to make Toyama Chemical subsidiary via tender offer

            Fujifilm to make Toyama Chemical subsidiary via tender offer

            TOKYO, Japan - Taisho Pharmaceutical Co. President Akira Uehara, Fujifilm Holdings Corp. President Shigetaka Komori and Toyama Chemical Co. President Masuji Sugata, (L to R) shake hands Feb. 13 after attending a news conference in Tokyo where Fujifilm said it will launch a friendly tender offer for shares in Toyama Chemical and turn the drug maker into a subsidiary. Fujifilm will acquire 66.7 percent of Toyama while Taisho, Toyama's current top shareholder with a 21.8 percent stake, will raise its stake by acquiring an additional 14.93 million Toyama shares.
              Comsn to sell nursing-care business after April

              Comsn to sell nursing-care business after April

              TOKYO, Japan - Koichi Higuchi (R), president of Comsn Inc., meets with Shinji Asonuma (L), director general of the Health and Welfare Bureau for the Elderly at the Health, Labor and Welfare Ministry in Tokyo on June 13.
                Comsn to sell nursing-care business after April

                Comsn to sell nursing-care business after April

                TOKYO, Japan - Koichi Higuchi (R), president of Comsn Inc., meets with Shinji Asonuma (L), director general of the Health and Welfare Bureau for the Elderly at the Health, Labor and Welfare Ministry in Tokyo on June 13. (Kyodo)
                  Gov't demands stricter checks at 7 nuclear plants to stem coveru

                  Gov't demands stricter checks at 7 nuclear plants to stem coveru

                  TOKYO, Japan - Economy, Trade and Industry Minister Akira Amari (L) hands a letter to Isao Nagahara, president of Hokuriku Electric Power Co., at his ministry on April 20, ordering the company, along with three others, to conduct additional checks on its nuclear power plant to prevent the recurrence of data falsification scandals involving nuclear reactors across the country. (Kyodo)
                    Gov't demands stricter checks at 7 nuclear plants to stem coveru

                    Gov't demands stricter checks at 7 nuclear plants to stem coveru

                    TOKYO, Japan - Tsunehisa Katsumata (C), president of Tokyo Electric Power Co., speaks with reporters on April 20 after his company, along with three others, was ordered by the Ministry of Economy, Trade and Industry to conduct additional checks on its nuclear power plants to prevent the recurrence of data falsification scandals involving nuclear reactors across the country. (Kyodo)
                      Mitsubishi Pharma, Tanabe Seiyaku to merge Oct. 1

                      Mitsubishi Pharma, Tanabe Seiyaku to merge Oct. 1

                      TOKYO, Japan - Natsuki Hayama (L), president of Tanabe Seiyaku Co., and Takeshi Komine, president of Mitsubishi Pharma Corp., shake hands during a press conference at a hotel in Tokyo on Feb. 2. They announced that the two mid-ranking pharmaceutical firms will merge Oct. 1.